Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: LEIDOS BIOMEDICAL RESEARCH INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-23 to 2026-03-31
Current total value of award: $14525306
Description: CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS